6351
|
Yin X, Wang Y, Liu B, Luo XB. Effects of the grain boundary on phase structure and surface morphology of TiO2
films prepared by MAO technology. SURF INTERFACE ANAL 2011. [DOI: 10.1002/sia.3792] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
6352
|
Zheng Q, Zhang L, Zhou X, Wang Q, Wang Y, Tang L, Song F, Huang D. C-shaped root canal system in mandibular second molars in a Chinese population evaluated by cone-beam computed tomography. Int Endod J 2011; 44:857-62. [DOI: 10.1111/j.1365-2591.2011.01896.x] [Citation(s) in RCA: 87] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
|
6353
|
Kurzeder C, Zhao L, Eisenhauer EA, Vergote IB, Du Bois A, Tai D, Wang Y, Gill JF, Hirte HW, Richter B, Hanker LC, Bentley J, Wagner UAG, Plante M, Kimmig R, Pfisterer J. The impact of dose intensity on the efficacy of gemcitabine plus carboplatin (GC) therapy for recurrent platinum-sensitive ovarian cancer (PSOC): A retrospective analysis of AGO-OVAR 2.5. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.5088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6354
|
Lai R, Xie L, Wu X, Zhang S, Du Y, Zhao S, Zheng Y, Sun Y, LI H, Chen J, LI Z, Liu L, Tang X, Wang L, Wang Y, Han M, Liu C, Wang J, Li H, Liu S. Gene expression signature comparison for solid tumor chemotherapy. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e21045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6355
|
Liu J, Albain KS, Chan S, Seidman AD, Tai D, Wang Y, Zhao L. Evaluation of response rate and disease control rate as potential predictors of overall survival in anthracycline-pretreated women receiving first-line chemotherapy for metastatic breast cancer (MBC). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.2552] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6356
|
Ko AH, Tempero MA, Shan Y, Su W, Lin Y, Dito E, Ong A, Wang Y, Yeh G, Chen L. A multinational phase II study of PEP02 (liposome irinotecan) for patients with gemcitabine-refractory metastatic pancreatic cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.4069] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6357
|
An T, Wang J, Bai H, Wu M, Zhao J, Duan J, Wang Y, Wang Z, Yang L. Retreatment after the failure of initial epidermal growth factor receptor inhibitor in non-small cell lung cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e18048] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6358
|
Heng DYC, Xie W, Harshman LC, Bjarnason GA, Vaishampayan UN, Lebert J, Wood L, Donskov F, Tan M, Rha SY, Wells C, Wang Y, Kollmannsberger CK, Rini BI, Choueiri TK. External validation of the International Metastatic Renal Cell Carcinoma (mRCC) Database Consortium prognostic model and comparison to four other models in the era of targeted therapy. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.4560] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6359
|
Vener TI, Derecho C, Galkin S, Greer J, Levis MJ, Gocke CD, Malek S, Palma JF, Raponi M, Wang Y, Wright JJ, Karp JE. Correlation of RASGRP1:APTX expression assay with response to tipifarnib plus etoposide in elderly patients with newly diagnosed AML. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.6534] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6360
|
Wang Y, Windham JP, Samul RA, Sanidad MA, Farooqui A, Gorman BM, Kelly JC, Meloni-Ehrig AM, Jones D. Subgroup classification of receptor tyrosine kinase (RTK) pathway activation in KRAS-mutated metastatic carcinoma. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e18019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6361
|
Wang Y, Zhang X, Wu YL. Homozygous deletion of ADAM3A revealed by genome-wide analysis of early-stage NSCLC in China showed to be correlated with poor prognosis. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e21177] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6362
|
Appanna KV, Zuber EPH, Jehl V, Zhang Y, Wang Y, racine-Poon A, Neuenschwander B. Using Bayesian proof-of-concept criteria to design randomized phase II oncology trials stratified by biomarker status. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e21150] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6363
|
Rhodes D, Tomlins SA, Freshley JK, Wyngaard P, Sadis S, Oades K, Chattopadhyay S, Kim H, Vo L, Telford D, Wang Y, Lee B, Monforte J. Identification of breast cancer genomic subtypes that associate with prognosis and response to therapy in retrospective analyses. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e21151] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6364
|
Berry WR, Fleming MT, Beer TM, Kolodziej MA, Awasthi S, Hutson TE, Martincic D, Wang Y, Asmar L, Sonpavde G. Association of rash with improved outcomes by the addition of cetuximab (C) to second-line mitoxantrone plus prednisone (MP) for progressive mCRPC after docetaxel-based chemotherapy. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e15040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6365
|
Wang Y. Intratumoral expression of mature human neutrophil peptides-1 increases the therapeutic effects of chemotherapy in mice. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e13517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6366
|
Zhu J, Wang J, Bai H, Zhao J, Wang Z, Zhuo M, An T, Duan J, Yang L, Wu M, Guo Q, Liu X, Wang S, Wang Y. Effect of wnt aberrant methylation and epidermal growth factor receptor pathway mutation on responsiveness of non-small cell lung cancer to gefitinib and erlotinib. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e18011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6367
|
Lee J, Petrini I, Hwang J, Giovannetti E, Voortman J, Wang Y, Steinberg SM, Funel N, Meltzer PS, Wang Y, Giaccone G. Array-based comparative genomic hybridization analysis to identify prognostic markers for resected pancreatic cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.4097] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6368
|
Wang F, Ding W, Wang J, Jing R, Wang X, Cong H, Wang Y, Ju S, Wang H. Identification of microRNA-target interaction in APRIL-knockdown colorectal cancer cells. Cancer Gene Ther 2011; 18:500-9. [PMID: 21597503 DOI: 10.1038/cgt.2011.19] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
MicroRNAs (miRNAs) regulate mammalian gene expression by targeting mRNAs and have key roles in several cellular processes, including differentiation, development, apoptosis and cancer pathomechanisms. Our previous studies have confirmed that a proliferation-inducing ligand (APRIL) gene is overexpressed in colorectal cancer (CRC) tumors and SW480 cells. To study the potential mechanisms of APRIL gene in the occurrence and development of the CRC, herein, we investigated whether APRIL-knockdown had the inhibitory effect on the growth of SW480 cells and had the simultaneous expression changes of miRNAs and mRNAs by microarrays. Our results suggest that siRNA-APRIL can effectively inhibit the growth of SW480 cells in vitro and in vivo and several miRNAs via specific pathways might be involved in regulating the phenotype of loss-of-function in APRIL-knockdown SW480 cells. Thus, our study highlights the possible mechanisms of miRNA-target regulating the function of APRIL gene in CRC cells, moreover, siRNA-APRIL holds great promise as a novel gene therapy approach for APRIL- positive CRC treatment.
Collapse
|
6369
|
Angevin E, Grünwald V, Ravaud A, Castellano DE, Lin CC, Gschwend JE, Harzstark AL, Chang J, Wang Y, Shi MM, Escudier BJ. A phase II study of dovitinib (TKI258), an FGFR- and VEGFR-inhibitor, in patients with advanced or metastatic renal cell cancer (mRCC). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.4551] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6370
|
Daraselia N, Wang Y, Budoff A, Lituev A, Potapova O, Monforte J, Ossovskaya V. Pathway analysis of primary human non-small cell lung cancer (NSCLC). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.10573] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6371
|
Wang F, Wang J, Bai H, Zhao J, Wang Z, Zhuo M, An T, Duan J, Yang L, Wu M, Wang Y, Wang S, Liu X. An evaluation of phosphorylated EGFR expression in predicting outcome of EGFR-TKI therapy for the advanced NSCLC patients with EGFR wild type. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.7532] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6372
|
Wang J, Chen K, Bai H, Zhao J, Wang Z, Zhuo M, An T, Duan J, Yang L, Wu M, Guo Q, Liu X, Wang S, Wang Y. Chemotherapy influence EGFR mutation status for Chinese patients with regionally advanced non-small cell lung cancer. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.7031] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6373
|
Xu J, Wang Y, Ye CY, Huang C, Zhang XH, Sai Y, Shen L, MU H. Phase I study on safety and pharmacokinetics of sulfatinib, a selective VEGFR/FGFR dual inhibitor, in Chinese patients with advanced solid tumors. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e13558] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6374
|
Yang J, Wang Y, Zhao H, Garnett C, Gobburu J, Pierce W, Schechter G, Summers J, Keegan P, Booth B, Rahman NA. Combination of exposure-response and case-control analyses in regulatory decision making. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.4087] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
6375
|
Parikh PM, Ranade A, Vaid AK, Advani SH, Bapna A, Zhu J, Wang Y, Ismail PM, Malik RK. The effect of talactoferrin on overall survival in prognostically important NSCLC subsets in a randomized, placebo-controlled phase II trial. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.7569] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|